PROGNOSTIC IMPLICATIONS OF PLASMA-LEVELS OF ATRIAL-NATRIURETIC-FACTOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

被引:6
作者
NAKAMURA, M
ARAKAWA, N
YOSHIDA, H
FUNAKOSHI, T
CHIBA, M
MAKITA, S
AOKI, H
HIRAMORI, K
机构
[1] Second Department of Internal Medicine, Iwate Medical University, Morioka
关键词
PROGNOSIS; HEART FAILURE; MORTALITY; HEMODYNAMICS; ATRIAL PRESSURE; AGE;
D O I
10.2169/internalmedicine.32.112
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several neurohormonal factors have been proposed as markers of the severity of acute myocardial infarction (MI). To determine whether plasma concentrations of atrial natriuretic factor (ANF) might predict post-MI prognosis, we studied 130 patients with acute MI (97 males and 33 females, mean age 62 years). Within one-half to one day after admission, a blood sample was taken for estimation of circulating ANF. The mean follow-up period was 37 months, and the follow-up rate was 97%. Of the 130 patients, 28 died from cardiac causes during the follow-up period. Patients were classified into three groups according to plasma ANF levels (group 1, < 99 pg/ml; group 2, 100-199 pg/ml; group 3 > 200 pg/ml). The survival curves were constructed by the Kaplan-Meier method. There were significant differences in the cumulative survival rate among the three groups (group 1 > group 2 > group 3; p < 0.001). The baseline characteristics (age, atrial pressure, and cardiac index) were different among the groups, therefore these variables were analyzed by a Cox multiple regression model. Significant predictors of cardiac mortality were plasma ANF class (p < 0.002) and pulmonary capillary wedge pressure (p < 0.007). In conclusion, these observations demonstrated that stratification of acute MI patients by plasma ANF level is a useful non-invasive method for predicting prognosis and for identifying individuals at high risk of cardiac death.
引用
收藏
页码:112 / 115
页数:4
相关论文
共 18 条
[1]  
Gottlieb S.S., Kukin M.L., Ahern D., Packer M., Prognostic importance of atrial natriuretic peptide-in patients with chronic heart failure, J Am Coll Cardiol, 13, (1989)
[2]  
Nakamura M., Yoshida H., Arakawa N., Chiba M., Aoki H., Hiramori K., Plasma atrial natriuretic factor in patients with acute myocardial infarction, Jpn Heart J, 33, (1992)
[3]  
Tan A.C.I.T.L., van Leonhout T.T., Lamfers E.J.P., Hooghoudt T.E.H., Kloppenborg P.W.C., Benraad T.J., Atrial natriuretic peptide after myocardial infarction, Am Heart J, 118, (1989)
[4]  
Fontana F., Bernardi P., Spagnolo N., Capelli M., Plasma atrial natriuretic factor in patients with acute myocardial infarction, Eur Heart J, 11, (1990)
[5]  
Nakamura M., Arakawa N., Kato M., Renal, hormonal, and hemodynamic effects of low-dose infusion of atrial natriuretic factor in acute myocardial infarction, Am Heart J, 120, (1990)
[6]  
Pasternak R.C., Braunwald E., Sobel B.E., Acute myocardial infarction, Heart Disease, (1992)
[7]  
Tomoda H., Atrial natriuretic peptide in acute myocardial infarction, Am J Cardiol, 62, (1988)
[8]  
Niitsuma K., Shimizu M., Kawaguchi T., Nakagami G., Kikawada R., Time course of released atrial natriuretic peptide after acute myocardial infarction, Jpn Circ J, 55, (1991)
[9]  
Killip T., Kimball J.T., Treatment of myocardial infarction in a coronary care unit, Am J Cardiol, 20, (1967)
[10]  
Mond H.G., Hunt D., Sloman G., Haemodynamic monitoring in the coronary care unit using the Swan-Ganz right heart catheter, Br Heart J, (1973)